WHO’s SAGE recommends use of Sanofi Pasteur’s dengue vaccine in endemic countries
It also recognised strong public health benefit to be gained by introduction of Dengvaxia, dengue vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dengue
Indian scientists develop breakthrough dengue drug
The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug
In a…
Dengvaxia dengue vaccine approved in the Philippines
The vaccine administered in three doses over a one-year period will help prevent the disease caused by all four dengue types in…
DBT to strengthen international linkages for research on infectious diseases and vaccine development
Initiates partnership proposal for research on human infectious diseases with Infect-ERA NET
A future strategy for Indo – US…
‘Caripill contains scientifically standardised dose of the papaya leaf extract’
Bengaluru-based Micro Labs recently launched Caripill which helps to increase the platelet count in patients suffering from…
Micro Labs launches Caripill, to aid in treatment of dengue
Aims to reduce the trauma, high cost of hospitalisation and platelet transfusion
Sanofi Pasteur’s vaccine candidate protects pre-adolescents to adults against dengue
Based on the clinical profile in nine years of age and older, the dengue vaccine candidate has the potential to significantly…
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published
Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation